Clinical Trial Update: A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study comparing the oral liquid formulation of topiramate with the marketed sprinkle capsule formulation to assess bioavailability in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED